Accelerate the Biotech Act, do not let tariffs derail Europe’s innovation drive: pharma experts

EU PERSPECTIVES - Europe's small and mid-sized pharma and biotech companies warn that trade politics risk distracting from the real priority: competitiveness and innovation. In spite of the largely unfavourable trade deal with the United States, the pharma sector should keep building a competitive, innovation-friendly environment. Read more

Alexander Natz, Secretary General, EUCOPE Photo credit: EUCOPE